DaVita exec reports equity grants, tax withholdings

DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported equity compensation grants and related tax withholdings.

Rhea-AI Filing Summary

DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported equity compensation grants and related tax withholdings. She received 8,610 stock appreciation rights tied to an equal number of common shares at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms. She also acquired 3,185 restricted stock units that are scheduled to vest on the same dates.

To cover tax obligations from the vesting of previously granted performance stock units and restricted stock units, 33,863 shares of common stock were withheld at $150.72 per share through several F-code transactions. Following these compensation-related grants and withholdings, Waters directly holds 124,599 shares of DaVita common stock.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Waters Kathleen Alyce

Role Chief Legal & Pub. Affairs Off

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Rights	8,610	$0.00	$0.00
Grant/Award	Common Stock	3,185	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,457	$150.72	$370K
Exercise Price or Tax Liability	Common Stock	26,118	$150.72	$3.94M
Exercise Price or Tax Liability	Common Stock	940	$150.72	$142K
Exercise Price or Tax Liability	Common Stock	4,348	$150.72	$655K

Holdings After Transaction: Stock Appreciation Rights — 8,610 contracts (Direct); Common Stock — 124,599 shares (Direct)

Footnotes (6)

1. F1. These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.
2. F2. Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 4,829 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2025 performance period and granted to the Reporting Person on March 15, 2022.
3. F3. Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 51,330 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2023 - 2025 performance period and granted to the Reporting Person on March 15, 2023.
4. F4. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 1,989 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2022.
5. F5. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 9,205 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2023.
6. F6. The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DaVita (DVA) executive Kathleen Alyce Waters receive in this Form 4 filing?

Kathleen Alyce Waters received equity compensation in the form of 8,610 stock appreciation rights and 3,185 restricted stock units. These awards increase her potential long-term equity exposure to DaVita, subject to vesting schedules and the specific terms of the award agreements.

How many DaVita (DVA) stock appreciation rights were granted to Kathleen Waters?

Kathleen Waters was granted 8,610 stock appreciation rights tied to DaVita common stock at an exercise price of $150.72 per share. These rights are scheduled to vest in two equal installments on March 15, 2029 and March 15, 2030, subject to award conditions.

What vesting schedule applies to Kathleen Waters’ new DaVita (DVA) equity awards?

Both the 8,610 stock appreciation rights and the 3,185 restricted stock units are scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030. Vesting remains subject to the terms and conditions of the applicable award agreements.

Why were DaVita (DVA) shares disposed of in Kathleen Waters’ Form 4?

The reported share dispositions were tax-withholding transactions. A total of 33,863 DaVita shares were withheld at $150.72 per share to satisfy tax obligations arising from the vesting of performance stock units and restricted stock units previously granted to Kathleen Waters.

How many DaVita (DVA) shares does Kathleen Waters hold after these transactions?

After the reported grant and tax-withholding transactions, Kathleen Waters directly holds 124,599 shares of DaVita common stock. This figure reflects the net position following the award of new shares and the withholding of shares to satisfy related tax liabilities.

Were any DaVita (DVA) shares sold on the open market by Kathleen Waters?

No open-market purchases or sales were reported in this Form 4. The only disposals were F-code transactions, where 33,863 shares were withheld by the issuer at $150.72 per share solely to cover tax obligations tied to vesting equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waters Kathleen Alyce

(Last) (First) (Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal & Pub. Affairs Off

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		3,185(1)	A	$0	158,462	D
Common Stock	03/15/2026		F		2,457(2)	D	$150.72	156,005	D
Common Stock	03/15/2026		F		26,118(3)	D	$150.72	129,887	D
Common Stock	03/15/2026		F		940(4)	D	$150.72	128,947	D
Common Stock	03/15/2026		F		4,348(5)	D	$150.72	124,599	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$150.72	03/15/2026		A		8,610		(6)	03/15/2031	Common Stock	8,610	$0	8,610	D

Explanation of Responses:

1. These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.

2. Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 4,829 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2025 performance period and granted to the Reporting Person on March 15, 2022.

3. Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 51,330 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2023 - 2025 performance period and granted to the Reporting Person on March 15, 2023.

4. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 1,989 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2022.

5. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 9,205 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2023.

6. The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.

Remarks:

	/s/ Stephanie N. Berberich, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.